Michael Eric Lisjak - 28 Feb 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Regulatory Officer
Signature
/s/ Michael Lisjak
Issuer symbol
CYTH
Transactions as of
28 Feb 2022
Net transactions value
$0
Form type
4
Filing time
02 Mar 2022, 15:33:46 UTC
Previous filing
30 Aug 2021
Next filing
09 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Options (Right to buy) Award $0 +31,141 $0.000000 31,141 28 Feb 2022 Common Stock 31,141 $3.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four year period in equal monthly installments.